Enlivex Therapeutics Ltd. (TLV:ENLV)
261.20
+15.20 (6.18%)
At close: Jan 6, 2026
-42.87% (1Y)
| Market Cap | 586.11M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -42.05M |
| Shares Out | n/a |
| EPS (ttm) | -1.79 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 119,571 |
| Average Volume | 158,772 |
| Open | 246.00 |
| Previous Close | 246.00 |
| Day's Range | 245.50 - 263.30 |
| 52-Week Range | 213.20 - 682.90 |
| Beta | 1.49 |
| RSI | 46.08 |
| Earnings Date | Mar 30, 2026 |